Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/19053Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choy, Matthew C | - |
| dc.contributor.author | De Cruz, Peter | - |
| dc.date.accessioned | 2018-09-13T00:14:46Z | - |
| dc.date.available | 2018-09-13T00:14:46Z | - |
| dc.date.issued | 2017-04 | - |
| dc.identifier.citation | Alimentary Pharmacology & Therapeutics 2017; 45(8): 1169-1170 | en_US |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/19053 | - |
| dc.language.iso | eng | - |
| dc.title | Letter: dose optimising infliximab in acute severe ulcerative colitis. | en_US |
| dc.type | Journal Article | en_US |
| dc.identifier.journaltitle | Alimentary Pharmacology & Therapeutics | en_US |
| dc.identifier.affiliation | Gastroenterology and Hepatology | en_US |
| dc.identifier.affiliation | Medicine (University of Melbourne) | en_US |
| dc.identifier.doi | 10.1111/apt.13980 | en_US |
| dc.type.content | Text | en_US |
| dc.identifier.orcid | 0000-0001-5206-0097 | en_US |
| dc.identifier.orcid | 0000-0002-3399-7236 | en_US |
| dc.identifier.pubmedid | 28326583 | - |
| dc.type.austin | Letter | - |
| dc.type.austin | Research Support, Non-U.S. Gov't | - |
| dc.type.austin | Comment | - |
| local.name.researcher | Choy, Matthew C | |
| item.openairetype | Journal Article | - |
| item.cerifentitytype | Publications | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.languageiso639-1 | en | - |
| crisitem.author.dept | Gastroenterology and Hepatology | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.